Supply Chain Disruptions : Issue: Dependency on global suppliers (especially China and India) creates vulnerability.
Impact: Shortages of Active Pharmaceutical Ingredients (APIs). Distribution delays. Quality control challenges.
Counterfeit and Substandard Drugs: Issue: Counterfeit medicines account for an estimated 10% of global drug trade, especially in low-income countries.
Impact: Endangers patient safety. Damages brand reputation. Causes legal and regulatory complications.
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.